Transversalis fascia plane block to reduce pain after kidney transplant
Comparison of the Analgesic Effects of Transversalis Fascia Plane Block in Renal Transplantation Surgery
See if a transversalis fascia plane block can reduce pain and opioid use after kidney transplant for adults aged 18–65 with ASA III.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Ankara Etlik City Hospital Government |
| Locations | 1 site (Altındağ, Ankara) |
| Trial ID | NCT07542028 on ClinicalTrials.gov |
What this trial studies
This interventional study compares postoperative pain control in two groups: patients who receive a transversalis fascia plane block and a control group receiving standard analgesia. Participants are adults undergoing kidney transplant who meet specific eligibility criteria (age 18–65, ASA III, BMI 18–30 kg/m2). The study measures postoperative pain scores, opioid consumption, and related recovery outcomes to determine whether the block improves analgesia and reduces opioid need. Patients with bleeding diathesis or outside the specified age, ASA, or BMI ranges are excluded.
Who should consider this trial
Good fit: Adults aged 18–65 undergoing kidney transplant with ASA III and a BMI between 18 and 30 kg/m2, without bleeding disorders, are the ideal candidates for this study.
Not a fit: Patients outside the 18–65 age range, with ASA scores other than III, with BMI below 18 or above 30, or with bleeding diathesis are unlikely to be eligible or to receive benefit from this intervention.
Why it matters
Potential benefit: If successful, the block could lower opioid use and improve pain control after kidney transplant, helping patients recover faster with fewer opioid-related side effects.
How similar studies have performed: Other peripheral nerve blocks have been shown to reduce postoperative opioid consumption after abdominal and transplant surgeries, but the use of the transversalis fascia plane block specifically in kidney transplant patients is less well studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18-65 years * American Society of Anesthesiologists (ASA) score III * Body Mass Index (BMI) between 18-30 kg/m2 Exclusion Criteria: * Patients under 18 and over 65 years of age * Patients with an ASA score other than III * Patients with a history of bleeding diathesis * BMI below 18 or above 30 kg/m2
Where this trial is running
Altındağ, Ankara
- Atakan Sezgi — Altındağ, Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Atakan Sezgi
- Email: kansezgi@gmail.com
- Phone: 00905323327000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.